PTC Therapeutics Inc.
PTCT | NASDAQ
$65.26
-$0.11 (-0.17%)
At close: Sep 21, 2026, 4:00 PM ET
$73.01
+$7.75 (+11.88%)
Pre-market:
Sep 22, 2026, 8:45 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.01B | 827.11M | 1.73B | 1.78B | 1.76B | 1.77B | 806.78M | 900.66M | 900.45M | 927.56M | 937.82M | 798.18M | 818.73M | 770.45M | 698.8M | 696.62M | 618.23M | 569.38M | 538.59M | 492.23M | 471.89M | 430.45M |
Cost of Revenue | 171.85M | 183.27M | 156.52M | 156.5M | 51.41M | 55.52M | 57.4M | 147.41M | 146.05M | 143.26M | 142.66M | 47.26M | 51.78M | 48.69M | 44.68M | 43.11M | 35.64M | 33.36M | 32.33M | 27.89M | 26.02M | 23.96M |
Gross Profit | 476.39M | 643.84M | 1.57B | 1.62B | 1.71B | 1.72B | 749.38M | 753.26M | 754.4M | 784.3M | 795.16M | 750.92M | 766.95M | 721.76M | 654.12M | 653.51M | 582.59M | 536.02M | 506.26M | 464.34M | 445.87M | 406.49M |
Operating Income | 116.26M | -67.68M | 856.66M | 775.9M | 718.37M | 713.11M | -302.57M | -137.06M | -200.72M | -370.04M | -442.2M | -645.66M | -600.99M | -483.81M | -452.71M | -337.1M | -356.69M | -362.82M | -374.45M | -386.09M | -348.15M | -436.93M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -67.07M | -235.67M | 696.62M | 741M | 666.09M | 651.41M | -363.12M | -425.47M | -494.07M | -645.82M | -696.11M | -728.75M | -689.37M | -600.59M | -587.49M | -536.4M | -542.85M | -512.04M | -518.34M | -441.45M | -355.2M | -418.66M |
Net Income | -38.38M | -186.73M | 682.64M | 751.72M | 629.17M | 594.84M | -363.3M | -453.2M | -479.52M | -579.22M | -626.6M | -641.7M | -618.05M | -571.25M | -559.02M | -531.39M | -555.7M | -521.99M | -523.9M | -454.99M | -391.06M | -454.12M |
Selling & General & Admin | 351.33M | 355.97M | 350.74M | 334.95M | 324.36M | 308.6M | 300.91M | 292.52M | 299.95M | 318.9M | 332.54M | 348.97M | 348.2M | 339.64M | 326M | 319.83M | 308.96M | 297.95M | 285.77M | 274.68M | 263.27M | 248.05M |
Research & Development | 433.31M | 447.15M | 455.25M | 446.89M | 508.15M | 527.32M | 534.48M | 531.06M | 533.86M | 587.57M | 666.56M | 733.9M | 735.15M | 706.54M | 651.5M | 612.65M | 578.03M | 546.25M | 540.68M | 508.85M | 471.01M | 522.05M |
Other Expenses | -63.99M | -91.59M | -88.52M | 64.91M | 162.64M | 168.21M | 216.56M | 66.74M | 121.31M | 247.88M | 238.26M | 313.71M | 284.58M | 159.38M | 129.34M | 58.13M | 52.29M | 54.65M | 54.25M | 66.9M | 59.74M | 73.32M |
Operating Expenses | 720.65M | 711.52M | 717.48M | 846.75M | 995.15M | 1B | 1.05B | 890.32M | 955.12M | 1.15B | 1.24B | 1.4B | 1.37B | 1.21B | 1.11B | 990.61M | 939.28M | 898.85M | 880.71M | 850.43M | 794.02M | 843.41M |
Interest Expense | -9.73M | 69.11M | 152.23M | 138.1M | 147.12M | 160.25M | 166.99M | 170.21M | 156.76M | 142.68M | 129.18M | 109.41M | 102.13M | 94.69M | 90.87M | 88.87M | 89.79M | 90.38M | 86.02M | 87.81M | 87.05M | 69.87M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.6M | -4.6M | -4.6M | -4.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 680.96M | 894.79M | 874M | 1B | 1.05B | 1.06B | 1.11B | 1.04B | 1.1B | 1.3B | 1.38B | 1.44B | 1.42B | 1.25B | 1.15B | 1.03B | 974.92M | 932.2M | 913.04M | 878.32M | 820.03M | 867.38M |
Income Tax Expense | -56.79M | -48.94M | 13.98M | -10.72M | 36.91M | 56.56M | 176K | 27.73M | -14.55M | -66.6M | -69.51M | -87.05M | -71.32M | -29.34M | -28.47M | -5.01M | 12.85M | 9.94M | 5.56M | 13.54M | 35.86M | 35.46M |
Shares Outstanding (Basic) | 83.01M | 82.52M | 80.69M | 81.5M | 78.15M | 78.12M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.45M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
Shares Outstanding (Diluted) | 92.02M | 82.52M | 80.69M | 87.12M | 78.15M | 86.39M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.65M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
EPS (Basic) | -0.49 | -2.33 | 8.79 | 9.61 | 8.02 | 7.56 | -4.73 | -5.94 | -6.31 | -7.68 | -8.36 | -8.65 | -8.42 | -7.89 | -7.79 | -7.47 | -7.83 | -7.38 | -7.43 | -6.51 | -5.65 | -6.75 |
EPS (Diluted) | -0.58 | -2.33 | 7.74 | 8.56 | 6.97 | 6.51 | -4.73 | -5.94 | -6.31 | -7.68 | -8.36 | -8.65 | -8.42 | -7.89 | -7.79 | -7.47 | -7.83 | -7.38 | -7.43 | -6.51 | -5.65 | -6.75 |
EBITDA | 62.53M | -119.56M | 887.66M | 911.78M | 841.26M | 839.15M | -120.46M | -105.66M | -129.66M | -251.49M | -327.86M | -422.11M | -416.86M | -357.34M | -364.57M | -335.54M | -362.01M | -344.8M | -368.19M | -295.92M | -215.53M | -300.95M |
EBIT | -125.87M | -166.56M | 848.85M | 879.11M | 813.21M | 811.66M | -196.13M | -255.26M | -337.31M | -503.13M | -566.93M | -619.35M | -587.24M | -505.9M | -496.62M | -447.53M | -453.06M | -421.66M | -432.32M | -353.64M | -268.15M | -348.79M |
Depreciation & Amortization | 39.42M | 47.01M | 38.82M | 32.68M | 28.05M | 27.49M | 75.66M | 149.6M | 207.66M | 251.64M | 239.07M | 197.23M | 170.38M | 148.56M | 132.05M | 111.99M | 91.06M | 76.86M | 64.13M | 57.73M | 52.62M | 47.84M |
Add to Watchlist
Select watchlists to add or remove PTCT